Who is Pharma Going to Blame When PBMs are Gone and Drug Prices are Still Crazy?

The pharmaceutical industry, who make our drugs (good) and then set outlandish prices for them (bad), has developed a unique logic to blame PBMs (Pharmacy Benefit Managers - the people whose job it is to negotiate lower prices for consumers) for the higher price of drugs.

Read more

Hospital Chargemasters Leading to Confused Patients, Questions About Costs

A new federal law praised for what some considered a giant leap toward increased healthcare transparency may be making an already-confusing experience even more confusing. The rule effective Jan. 1 requires hospitals to publicize prices online for any services they offer. Unfortunately for patients, early reports on the process have not been favorable.

Read more

Generic Insulin Could Lower Costs, but Red Tape and Prescribing Habits Won’t Make It Easy

Imagine you spend years fine-tuning formulas and undergoing tests, trials, and experiments, before finally developing a potentially life-saving drug. And then two of your neighbors do the same. Over the next century or so, the three of you control the overwhelming majority of the market for that drug, raising prices as you wish and leaving little room for competition or a generic alternative.

Read more


Sign in with Facebook, Twitter or email.